Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Jul 30,2015
Preclinical CRO - Medicilon
Medicilon (stock code: 688202. SH) is a drug research and development outsourcing service company (CRO). Pharmacology, pharmacokinetics, and toxicology evaluation are comprehensive technical service platforms that meet international standards.
More
Preclinical CRO - Medicilon
Jun 11,2015
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Suzhou NeuPharma Co., Ltd announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.  RX108 is a novel small-molecule inhibitor
More
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Jun 09,2015
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Dr. Chunlin Chen, Medicilon's CEO, was the host of the seminar in Tokyo and Osaka and gave a wonderful speech with the topic "Current Pharmaceutical
More
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Mar 31,2015
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea
On March 18, Medicilon hosted a CFDA IND seminar with Korea Pharmaceutical Manufacturers Association (KPMA) in Seoul, South Korea.  The seminar's topic was "Experience Sharing
More
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea
Mar 16,2015
Medicilon was interviewed by CCTV NEWS English Channel
CCTV NEWS English Channel launched the special news program, "Free Trade Zone Self-Break and Outlook” during the "Lianghui”, the annual plenary sessions.  As Zhangjiang Hi-Tech
More
Medicilon was interviewed by CCTV NEWS English Channel
Mar 06,2015
Medicilon held Chinese New Year Gala Dinner in USA
On Feb 6, 9 and 12, Medicilon held 3 Chinese New Year & 10th Anniversary Gala Dinners in San Francisco, San Diego and Boston respectively.
More
Medicilon held Chinese New Year Gala Dinner in USA
Feb 06,2015
2015 Shanghai Medicilon Annual Dinner — Work together to get a brighter future
The 2015 Shanghai Medicilon and Medicilon Preclinical Annual Dinner was successfully held on Feb 6.  Medicilon wish you a Happy New Year. On Feb 6,
More
2015 Shanghai Medicilon Annual Dinner — Work together to get a brighter future
Feb 02,2015
Medicilon passed Guangdong FDA review and examination
Medicilon provides different kinds of animal disease models for pharmacology services such as Cancer Xenograft Models, Neurological Disorders Models, Inflammation & Immunological Disease Models and
More
Medicilon passed Guangdong FDA review and examination
Feb 02,2015
Medicilon's in Vitro and in Vivo Pharmacology Test Successfully Passed the Review by China Food and Drug Administration
The Drug Metabolism Professional Committee of 4th Shanghai Pharmacological Societyand the 1st Symposium was held at Zhangjiang campus, Fudan University on January 29.  Dr. Chunlin
More
Medicilon's in Vitro and in Vivo Pharmacology Test Successfully Passed the Review by China Food and Drug Administration
Jan 15,2015
Medicilon congratulated AD16 is officially accepted by CFDA for clinical trial
Recently, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science and South China Center for Innovative Pharmaceuticals' "Class 1.1 piperazine da ketone chemical drugs”
More
Medicilon congratulated AD16 is officially accepted by CFDA for clinical trial
Dec 31,2014
Medicilon wish you a Happy New Year
The year of 2014 is a successful year to Medicilon.  Medicilon would like to take this opportunity to thank you for the support from all
More
Medicilon wish you a Happy New Year
Dec 19,2014
Dr. Chen was invited to participate in the First Guangzhou Multinational Pharmaceutical R&D Summit
Pharmaceutical innovation is the energy to upgrade the industrial structure.  The First Guangzhou Multinational Pharmaceutical R&D Summit, which is co-hosted by Guangzhou Service Center for
More
Dr. Chen was invited to participate in the First Guangzhou Multinational Pharmaceutical R&D Summit
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->